スキンケアデバイスの世界市場規模・シェア・開発・成長・需要予測（2013～2023年)：商品別(光・LED治療・フォトトリートメント、脂肪吸引、電気手術、レーザー治療、クライオセラピー、マイクロダーマブレージョン、皮膚鏡、生検装置、画像誘導システム)・用途別(セルライト除去、疾患診断・治療、脱毛、スキンタイトニング・体形矯正、若返り術)・地域別(米国、カナダ、ドイツ、イギリス、フランス、イタリア、スペイン、日本、中国、インド、オーストラリア、ブラジル、メキシコ、南アフリカ、イスラエル、サウジアラビア、アラブ首長国連邦)

2018年3月2日 // 0 Comments

The growth in the skincare devices market will be led by increasing cases of skin cancer and skin related disorders, technological advancements in skincare devices, increase in disposable income, rising demand for aesthetic procedures, and growing geriatric population.
Insights on market segments

The products used in the skincare devices market have been categorized as skin treatment devices and skin diagnostic devices. The market for the latter is expected to witness the fastest growth at a CAGR of 11.9% during the forecast period. This rising demand for skincare diagnostic devices can be attributed to the increasing prevalence of skin diseases, especially skin cancer, the diagnosis of which requires the use of these devices.

Skin treatment devices held the largest share in the skincare devices market in 2017. These devices include light/LED therapy and photorejuvenation, liposuction, electrosurgical, laser based, cryotherapy, microdermabrasion, and others. Light/LED therapy and photorejuvenation devices are estimated to capture the largest share of the skin treatment devices market in 2017. This is due to the worldwide growth in aging population, and increasing popularity of these devices as a way to fight acne, and many signs of aging. Laser based devices are expected to witness the fastest growth in demand, at a CAGR of 11.9% during the forecast period.

Cellulite reduction is the largest application category in the skincare devices market, which can be attributed to the high prevalence (80%–90%) of cellulite in post-pubertal female patients of all races and rising ageing population. On the other hand, the skin tightening and body contouring application category is expected to witness the fastest growth in demand for skincare devices, during the forecast period. The growth for skin tightening and body contouring services is driven by the increasing prevalence of obesity and growing number of people undergoing liposuction, who in turn require skin tightening for avoiding the problem of loose skin.

Asia-Pacific (APAC) is the fastest growing market for skincare devices

The skincare devices are expected to witness the fastest growth in demand in APAC, at a CAGR of 12.5% during the forecast period, owing to a large population, higher prevalence of skin diseases and obesity, and aging population in the region.

According to the United Nations Economic and Social Commission for Asia and the Pacific (UNESCAP), people aged 65 years and above constituted approximately 11.4% of the population in 2013, and the count is estimated to increase by approximately 20% by 2050. The geriatric population is at a greater risk of skin cancer. According to the Skin Cancer Foundation, the majority of people diagnosed with melanoma are white men, above 55 years of age. Also, the elderly people generally face problems such as wrinkles, cellulite, loose skin, obesity and therefore, fueling the growth of the APAC skincare devices market.

Key Players Look to Technological Advancements for Market Expansion

The key players in the skincare devices industry are developing and launching new skincare devices that are equipped with latest technology, to gain a larger market share. For instance, in May 2017, Cutera Inc. launched truSculpt 3D, a new technology in body sculpting that offers up to 24% fat reduction in a single operation.

Some of the other key players operating in the skincare devices market include Allergan plc, Merz Pharma GmbH & Co. KGaA, Syneron Medical Ltd., Michelson Diagnostic Ltd., Lumenis Ltd., PhotoMedex Inc., Alma Lasers Ltd., Hologic Inc., Panasonic Corporation, Valeant Pharmaceuticals International Inc., and Beijing Toplaser Technology Co Ltd.

オッセオインテグレーションインプラントの世界市場規模・シェア・開発・成長・需要予測（2013～2023年)：商品別(骨支持型義肢(脊椎固定、聴覚、上腕用義肢、下肢用義肢)歯科用インプラント(クラウン、インプラント、アバットメント))・素材別(メタリック、セラミクス、高分子)・エンドユーザー別(病院、歯科クリニック、ASC)・地域別(米国、カナダ、ドイツ、フランス、イギリス、日本、オーストラリア、インド、中国)

2018年3月2日 // 0 Comments

The growth in the market will be led by the increasing prevalence of spinal cord injuries, rise in the number of dental implant surgeries, reimbursement support by government and other organizations, rising number of trauma incidents, increasing hearing loss cases in the geriatric population, and spur in the funding for osseointegration research.
Insights on market segments

In terms of product type, the osseointegration implants market has been categorized as dental implants and bone-anchored prostheses. Dental implants are expected to witness a faster growth in demand, with a CAGR of 4.6% during the forecast period, owing to increasing prevalence of dental disorders and rising awareness about dental implants as a tooth-loss solution.

By material type, ceramic biomaterials are expected to project the fastest growth in demand with a CAGR of 4.2% during the forecast period. The growth of ceramic biomaterials is attributed to their tribological properties, biocompatibility, and aesthetic appearance. On the basis of end user, the osseointegration implants industry is categorized into hospitals, ambulatory surgical clinics (ASCs), and dental clinics. Due to the increasing number of dental implant procedures worldwide, the demand of osseointegration implants in dental clinics is expected to advance at a CAGR of 3.4% during the forecast period.

Asia-Pacific to exhibit fastest growth, with 4.8% CAGR during the forecast period

The osseointegration implants market in Asia-Pacific is expected to witness a significant growth during the forecast period. This growth is attributed to factors such as increasing development and research activities, rising disposable income that enables people to select appropriate treatment options, and access to modern healthcare facilities.

Technologically advanced countries such as Australia, are increasingly focusing on the development of implantable procedures for upper and lower limb amputees, enabling the manufacturers of osseointegration implants in bone-prostheses to grow significantly in this region. Moreover, the increasing dental tourism in countries such as India and Thailand have facilitated the growth of the osseointegration market for dental implants.

Major players launching innovative products to gain a larger market share

Globally, the key providers in the osseointegration implants industry are launching new products to gain a larger market share. For instance, in June 2017, DePuy Synthes Companies announced the launch of the VIPER and EXPEDIUM Fenestrated Screw Systems in the U.S. The system along with CONFIDENCE High Viscosity Spinal Cement would restore the integrity of the spinal column in patients with advanced stage spinal tumors.

Similarly, in January 2017, Integrum AB launched the new OPRA Implant System Platform G, which is to be used for transfemoral patients. The new platform is CE labeled and approved by the USFDA, which improves the mechanical performance of the system, simplifies the surgical procedure, and enhances osseointegration.

Some of the other key players operating in the osseointegration implants market include Zimmer Biomet Holdings Inc., Dentsply Sirona Inc., Danaher Corporation, The Straumann Group, Henry Schein Inc., Stryker Corporation, NuVasive, Inc., William Demant Holding A/S, Cochlear Ltd., and Medtronic plc.

ヘルスケアコグニティブコンピューティングの世界市場規模・シェア・開発・成長・需要予測（2014～2024年)：技術別(自然言語処理(NLP)、機械学習、自動推論、情報検索)・展開モデル別(オンクラウド、オンプレミス)・エンドユーザー別(ヘルスケアプロバイダー、医薬品企業、医療機器企業、ヘルスケアペイヤー)、・地域別(米国、カナダ、イギリス、ドイツ、フランス、中国、日本、インド、ブラジル)

2018年3月2日 // 0 Comments

The growth in the healthcare cognitive computing market size will be led by increasing burden of chronic diseases, technological advancements in the healthcare industry encouraging the use of cognitive computing in healthcare, and rising adoption of third computing platforms.
Insights on market segments

The technologies used in the healthcare cognitive computing market have been categorized as natural language processing (NLP), machine learning, automated reasoning, and information retrieval, where NLP is expected to witness the fastest growth in demand, and is likely to garner a CAGR of 34.9% during the forecast period. This rising demand for the NLP technology can be attributed to its comprehensive evaluation process, which facilitates management of patient feedback and enables clinical staff to make informed decisions and respond to problems in real time. For instance, the U.S. based Intermountain Hospital uses the NLP technology to identify information associated with cardiac patients, cancer patients, and venous thromboembolism patients.

Cloud and on-premise are the two major types of deployment models used in the healthcare cognitive computing market. Globally, the cloud computing deployment model is estimated to acquire a larger market share, standing at 71.0% in 2017. This growth in the cloud computing deployment model is mainly attributed to its increasing use in the development of healthcare applications, such as electronic health records (EHRs), which are affordable and easily accessible to the healthcare providers to store and access data remotely and provide the necessary care without any delay.

Although cognitive computing is being increasingly used in healthcare by various healthcare professionals, it is the healthcare providers category that is expected to witness the fastest growth, as the end-user base, in the healthcare cognitive computing market during the forecast period. Healthcare providers have been estimated to lead the global market, occupying a 44.5% share in 2017. This growth in the demand for healthcare cognitive computing solutions by healthcare providers can be attributed to the increased usage of cognitive platforms by the providers for the detection and treatment of rare diseases. For instance, in October 2016, Rhön-Klinikum AG, a private hospital group in Germany, teamed up with IBM Corporation on a 12-month pilot project to help detect rare diseases and find their cure using the IBM’s Watson platform.

Asia-Pacific (APAC) is the fastest growing market for healthcare cognitive computing solutions

The APAC healthcare cognitive computing industry is expected to witness the fastest growth in demand, at a CAGR of 41.6%, during the forecast period, owing to rising geriatric population, increasing healthcare expenditure, growing public and private investments in the healthcare sector to cater to unmet medical needs, and burgeoning pharmaceutical industry in the region.

According to the United Nations Economic and Social Commission for Asia and the Pacific (UNESCAP), people aged 65 years and above constituted approximately 11.4% of the population in 2013, and the count is estimated to increase by approximately 20% by 2050. Since the elderly generally need help in meeting their medication needs, including keeping track of their visits to the doctor, medication timings, exercise reminders, and dietary recommendations, there is ample scope for the healthcare cognitive computing market to flourish in the region.

Companies in the healthcare cognitive computing market are also increasingly getting involved in research and development to provide better healthcare solutions. For instance, in August 2016, IBM Watson aided in the detection of a rare form of leukemia in a patient in Japan. The cloud-based, AI-powered supercomputer of IBM is capable of cross-referencing and analyzing data from millions of oncology papers from research institutes all over the world.

Development of advanced healthcare computing solutions by key players, to gain a larger share

Globally, key players in the healthcare cognitive computing industry are developing advanced computing solutions for healthcare, to gain a larger market share. For instance, in November 2017, Nuance Communications Inc. unveiled Nuance AI Marketplace for Diagnostic Imaging at the Radiological Society of North America (RSNA) conference in Chicago. It is the first open platform for developers, data scientists, and radiologists to accelerate the development, deployment, and adoption of AI for medical imaging.

Some of the other key players operating in the healthcare cognitive computing market include IBM Corporation, Microsoft Corporation, Enterra Solutions, LLC, Intel Corporation, Alphabet Inc., Hewlett Packard Enterprise (HPE), CognitiveScale, Healthcare X.0 GmbH, and MedWhat.com Inc.